Identifying Important Risk Indicators in Clinical Development

Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams and considered an essential component of centralized monitoring.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Press Release

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...

Press Release

CluePoints Appoints Martin Magazzolo as Chief Commercial Officer

Wayne, PA – July 27, 2026 – CluePoints, provider of leading statistical and AI-driven software solutions,...

Press Release

CluePoints and Tufts CSDD Publish Peer-Reviewed Evidence Quantifying the Financial Value of RBQM

New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing...